Shivalik Rasayan Ltd.

270.490.59%

2026-08-21

shivalikrasayan.comBSE: 539148NSE: SHIVALIK
Market Cap₹ 402 Cr.
Current Price₹ 269
High / Low₹ 522 / 206
Stock P/E29.4
Book Value₹ 338
Price to Book2.87
Dividend Yield0.20 %
ROCE7.7 %
ROE6.0 %
Face Value₹ 5

Add ratio to table

ABOUT

KEY POINTS

PROS

  • Latest quarter profit grew 59.6% YoY, showing strong momentum
  • Company has consistently been profitable over the last 5 years
  • Company has a consistent dividend-paying track record
  • Company maintains a comfortable, low leverage position

CONS

  • Operating cash flow has been negative in recent years
  • A large part of profit comes from other income (35.5% of PBT)
  • Company has a low return on capital employed of 9.1%
  • Company has a low return on equity of 7.8% over last 3 years
  • Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -0.53x)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

EDIT COLUMNS
S.No.NameCMP Rs.P/EMar Cap Rs.Cr.Div Yld %NP Qtr Rs.Cr.Qtr Profit Var %Sales Qtr Rs.Cr.Qtr Sales Var %ROCE %OPM %
1.UPL568.7023.7748007.911.05-73.0058.5210181.0010.4712.0013.43
2.PIIND2496.0032.5137868.840.60244.20-38.951702.30-10.4316.0021.69
3.SUMICHEM553.6547.6927635.200.23214.5120.451063.350.6223.3921.94
4.BAYERCROP4068.40329.9918284.243.69321.6015.391835.00-4.1630.0820.03
5.SHARDACROP771.8011.126963.221.9488.02-38.361073.779.0331.1017.32
6.DHANUKA995.2014.944436.430.2075.5027.94442.0220.0124.4424.83
7.RALLIS211.9025.104120.801.42-14.15-274.26507.547.7013.23-0.56
8.NACLIND174.00329.494075.830.0020.8459.82383.33-14.506.2010.80
9.BHAGCHEM290.25136.753763.650.05133.293249.841950.191475.554.5515.65
10.GSPCROP595.3528.292769.490.17263.941111.463859.951153.2720.8111.02
11.BHARATRAS1279.9014.852127.330.04372.30838.733381.60796.0316.6315.19
12.SHIVALIK255.0029.38401.630.204.5059.5596.347.877.6911.61
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023
64
53
Operating Profit
OPM %
Other Income
0
Interest
1
Depreciation
3
8
Tax %
13.72%
Net Profit
0
3
Equity Capital
7
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
7
Reserves
0
Promoter Pledge %
0.00%
Sep 2023
67
57
Operating Profit
OPM %
Other Income
1
Interest
2
Depreciation
3
5
Tax %
45.11%
Net Profit
0
1
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Dec 2023
70
61
Operating Profit
OPM %
Other Income
2
Interest
2
Depreciation
3
6
Tax %
24.74%
Net Profit
0
2
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Mar 2024
71
62
Operating Profit
OPM %
Other Income
1
Interest
3
Depreciation
3
5
Tax %
9.09%
Net Profit
0
2
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Jun 2024
75
65
Operating Profit
OPM %
Other Income
1
Interest
2
Depreciation
4
5
Tax %
16.09%
Net Profit
4
2
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Sep 2024
82
71
Operating Profit
OPM %
Other Income
0
Interest
2
Depreciation
5
5
Tax %
11.58%
Net Profit
4
3
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Dec 2024
85
72
Operating Profit
OPM %
Other Income
2
Interest
2
Depreciation
5
8
Tax %
11.25%
Net Profit
7
3
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Mar 2025
69
64
Operating Profit
OPM %
Other Income
6
Interest
3
Depreciation
3
6
Tax %
13.21%
Net Profit
5
3
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Jun 2025
89
78
Operating Profit
OPM %
Other Income
1
Interest
3
Depreciation
5
4
Tax %
32.05%
Net Profit
3
1
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Sep 2025
94
82
Operating Profit
OPM %
Other Income
0
Interest
2
Depreciation
5
5
Tax %
21.35%
Net Profit
4
2
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Dec 2025
82
72
Operating Profit
OPM %
Other Income
1
Interest
2
Depreciation
5
4
Tax %
11.14%
Net Profit
4
2
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Mar 2026
103
90
Operating Profit
OPM %
Other Income
2
Interest
2
Depreciation
4
8
Tax %
7.12%
Net Profit
7
3
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Jun 2026
96
92
Operating Profit
OPM %
Other Income
1
Interest
2
Depreciation
4
6
Tax %
20.45%
Net Profit
5
0
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
8
Reserves
0
Promoter Pledge %
0.00%

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016
110
99
Operating Profit
12
OPM %
11
Other Income
1
Interest
5
Depreciation
2
5
Tax %
33
Net Profit
3
EPS
0
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
4
Minority Interest
0
Share of Associates
0
Adjusted EPS
4
Mar 2017
123
105
Operating Profit
19
OPM %
16
Other Income
1
Interest
6
Depreciation
2
11
Tax %
25
Net Profit
8
EPS
0
Dividend Payout %
6
Minority Interest
-3
Share of Associates
0
Adjusted EPS
6
Minority Interest
-3
Share of Associates
0
Adjusted EPS
6
Mar 2018
155
131
Operating Profit
27
OPM %
17
Other Income
3
Interest
4
Depreciation
2
20
Tax %
25
Net Profit
15
EPS
0
Dividend Payout %
5
Minority Interest
-6
Share of Associates
0
Adjusted EPS
9
Minority Interest
-6
Share of Associates
0
Adjusted EPS
9
Mar 2019
171
147
Operating Profit
32
OPM %
19
Other Income
8
Interest
3
Depreciation
3
26
Tax %
20
Net Profit
21
EPS
0
Dividend Payout %
5
Minority Interest
-7
Share of Associates
0
Adjusted EPS
10
Minority Interest
-7
Share of Associates
0
Adjusted EPS
10
Mar 2020
186
157
Operating Profit
32
OPM %
17
Other Income
3
Interest
2
Depreciation
4
27
Tax %
17
Net Profit
22
EPS
0
Dividend Payout %
2
Minority Interest
-8
Share of Associates
0
Adjusted EPS
10
Minority Interest
-8
Share of Associates
0
Adjusted EPS
10
Mar 2021
198
159
Operating Profit
40
OPM %
20
Other Income
1
Interest
2
Depreciation
9
29
Tax %
15
Net Profit
25
EPS
13
Dividend Payout %
4
Minority Interest
-7
Share of Associates
0
Adjusted EPS
13
Minority Interest
-7
Share of Associates
0
Adjusted EPS
13
Mar 2022
215
167
Operating Profit
51
OPM %
24
Other Income
4
Interest
3
Depreciation
11
37
Tax %
7
Net Profit
34
EPS
18
Dividend Payout %
3
Minority Interest
-9
Share of Associates
0
Adjusted EPS
18
Minority Interest
-9
Share of Associates
0
Adjusted EPS
18
Mar 2023
234
191
Operating Profit
48
OPM %
21
Other Income
5
Interest
5
Depreciation
12
32
Tax %
6
Net Profit
30
EPS
14
Dividend Payout %
3
Minority Interest
-9
Share of Associates
0
Adjusted EPS
14
Minority Interest
-9
Share of Associates
0
Adjusted EPS
14
Mar 2024
273
232
Operating Profit
45
OPM %
16
Other Income
4
Interest
9
Depreciation
12
23
Tax %
22
Net Profit
18
EPS
8
Dividend Payout %
6
Minority Interest
-5
Share of Associates
0
Adjusted EPS
8
Minority Interest
-5
Share of Associates
0
Adjusted EPS
8
Mar 2025
312
271
Operating Profit
49
OPM %
16
Other Income
8
Interest
10
Depreciation
16
23
Tax %
13
Net Profit
20
EPS
11
Dividend Payout %
5
Minority Interest
-4
Share of Associates
0
Adjusted EPS
11
Minority Interest
-4
Share of Associates
0
Adjusted EPS
11
TTM
375
336
Operating Profit
OPM %
Other Income
4
Interest
9
Depreciation
18
23
Tax %
15
Net Profit
20
EPS
Dividend Payout %
Minority Interest
0
Share of Associates
0
Adjusted EPS
Minority Interest
0
Share of Associates
0
Adjusted EPS

COMPOUNDED SALES GROWTH

10 Years:
22%
5 Years:
11%
3 Years:
13%

COMPOUNDED PROFIT GROWTH

10 Years:
25%
5 Years:
4%
3 Years:
-13%

STOCK PRICE CAGR

10 Years:
5 Years:
3 Years:
-29%
1 Year:
-48%

RETURN ON EQUITY

10 Years:
24%
5 Years:
11%
3 Years:
8%
Last Year:
6%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2018

Apr 19

1:4

Bonus issue & Stock Split Inter alia, to consider and approve, subject to requisite approvals: 1. Sub-division of Equity Shares of the Company; 2. Alteration of the Authorised Share Capital of the Company; 3. Alteration of the Memorandum and Articles of the Company in accordance with the Companies Act, 2013; 4. Issue of Bonus Shares to the Shareholders of the Company; 5. Diversification of the business of the Company in Pharmaceuticals and Speciality Chemicals and resulting alteration in the main objects of the Company; 6. Setting up a US FDA & EU level state of art Pharmaceuticals API & Intermediates manufacturing plant in Dahej, Gujarat; 7. Raising of funds by way of fresh issue of equity shares through preferential / rights / public offer/ institutional placement and Loans, as may be deemed fit for setting up the said Pharmaceuticals API & Intermediates manufacturing plant in Dahej, Gujarat; 8. Appointment of Dr. Akshay Kant Chaturvedi as an Executive Director on the Board of the Company 9. Appointment of Mr. Sanjay Bansal as Director on the Board of the Company; 10. Resignation of Mr. Rajiv Mehta from the Directorship of the Company; 11. Re-classification of M/s. NIAM International Private Limited as non-promoter entity, for which the Company has received a request letter dated February 24, 2018 from the said shareholder; and 12. To consider seeking approval of the Shareholders of the Company through postal ballot for the requisite items referred above. Further, pursuant to the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and as per the terms of the "Code of Conduct for prevention of Insider Trading" of the Company, the trading window shall remain closed from Monday, February 26, 2018 to Tuesday, March 06, 2018 (both days inclusive) for the Directors and specified persons as defined in the Code of Conduct.

Mar 2016
Equity Capital
3
11
16
Trade Payables
28
23
Total Liabilities
81
27
Capital Work in Progress
0
12
0
Cash & Bank
3
38
Total Assets
81
Total Debt
31
Net Working Capital
-2
Contingent Liabilities
0
Book Value per Share
39.44
Face Value
10.00
Total Debt
31
Net Working Capital
-2
Contingent Liabilities
0
Book Value per Share
39.44
Face Value
10.00
Mar 2017
Equity Capital
3
7
14
Trade Payables
27
43
Total Liabilities
94
27
Capital Work in Progress
0
15
0
Cash & Bank
5
46
Total Assets
94
Total Debt
32
Net Working Capital
9
Contingent Liabilities
0
Book Value per Share
28.89
Face Value
10.00
Total Debt
32
Net Working Capital
9
Contingent Liabilities
0
Book Value per Share
28.89
Face Value
10.00
Mar 2018
Equity Capital
4
45
14
Trade Payables
26
63
Total Liabilities
152
40
Capital Work in Progress
0
17
0
Cash & Bank
26
68
Total Assets
152
Total Debt
22
Net Working Capital
57
Contingent Liabilities
0
Book Value per Share
113.31
Face Value
10.00
Total Debt
22
Net Working Capital
57
Contingent Liabilities
0
Book Value per Share
113.31
Face Value
10.00
Mar 2019
Equity Capital
7
158
14
Trade Payables
34
76
Total Liabilities
288
41
Capital Work in Progress
26
21
0
Cash & Bank
95
105
Total Assets
288
Total Debt
20
Net Working Capital
150
Contingent Liabilities
0
Book Value per Share
117.19
Face Value
5.00
Total Debt
20
Net Working Capital
150
Contingent Liabilities
0
Book Value per Share
117.19
Face Value
5.00
Mar 2020
Equity Capital
7
169
8
Trade Payables
47
98
Total Liabilities
328
52
Capital Work in Progress
102
20
0
Cash & Bank
9
146
Total Assets
328
Total Debt
12
Net Working Capital
83
Contingent Liabilities
0
Book Value per Share
120.81
Face Value
5.00
Total Debt
12
Net Working Capital
83
Contingent Liabilities
0
Book Value per Share
120.81
Face Value
5.00
Mar 2021
Equity Capital
7
172
18
Trade Payables
44
122
Total Liabilities
363
210
Capital Work in Progress
0
10
0
Cash & Bank
5
138
Total Assets
363
Total Debt
30
Net Working Capital
40
Contingent Liabilities
0
Book Value per Share
119.70
Face Value
5.00
Total Debt
30
Net Working Capital
40
Contingent Liabilities
0
Book Value per Share
119.70
Face Value
5.00
Mar 2022
Equity Capital
7
270
30
Trade Payables
56
124
Total Liabilities
487
221
Capital Work in Progress
3
38
0
Cash & Bank
71
154
Total Assets
487
Total Debt
41
Net Working Capital
127
Contingent Liabilities
0
Book Value per Share
180.88
Face Value
5.00
Total Debt
41
Net Working Capital
127
Contingent Liabilities
0
Book Value per Share
180.88
Face Value
5.00
Mar 2023
Equity Capital
7
287
45
Trade Payables
66
170
Total Liabilities
575
218
Capital Work in Progress
57
75
0
Cash & Bank
31
194
Total Assets
575
Total Debt
66
Net Working Capital
118
Contingent Liabilities
0
Book Value per Share
182.23
Face Value
5.00
Total Debt
66
Net Working Capital
118
Contingent Liabilities
0
Book Value per Share
182.23
Face Value
5.00
Mar 2024
Equity Capital
8
378
52
Trade Payables
52
198
Total Liabilities
688
214
Capital Work in Progress
117
102
87
Cash & Bank
38
131
Total Assets
688
Total Debt
86
Net Working Capital
135
Contingent Liabilities
0
Book Value per Share
213.30
Face Value
5.00
Total Debt
86
Net Working Capital
135
Contingent Liabilities
0
Book Value per Share
213.30
Face Value
5.00
Mar 2025
Equity Capital
8
407
77
Trade Payables
66
169
Total Liabilities
728
337
Capital Work in Progress
0
118
96
Cash & Bank
28
149
Total Assets
728
Total Debt
105
Net Working Capital
136
Contingent Liabilities
0
Book Value per Share
218.42
Face Value
5.00
Total Debt
105
Net Working Capital
136
Contingent Liabilities
0
Book Value per Share
218.42
Face Value
5.00

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016
12
Cash from Investing
-18
Cash from Financing
3
-3
Free Cash Flow
-10
OCF / Net Profit
3.94
Cumulative 5-Year FCF
0
OCF / Net Profit
3.94
Cumulative 5-Year FCF
0
Mar 2017
8
Cash from Investing
-4
Cash from Financing
-3
2
Free Cash Flow
5
OCF / Net Profit
0.96
Cumulative 5-Year FCF
0
OCF / Net Profit
0.96
Cumulative 5-Year FCF
0
Mar 2018
-7
Cash from Investing
-24
Cash from Financing
52
21
Free Cash Flow
-22
OCF / Net Profit
-0.46
Cumulative 5-Year FCF
0
OCF / Net Profit
-0.46
Cumulative 5-Year FCF
0
Mar 2019
-8
Cash from Investing
-24
Cash from Financing
100
69
Free Cash Flow
-36
OCF / Net Profit
-0.37
Cumulative 5-Year FCF
0
OCF / Net Profit
-0.37
Cumulative 5-Year FCF
0
Mar 2020
6
Cash from Investing
-102
Cash from Financing
10
-86
Free Cash Flow
-84
OCF / Net Profit
0.26
Cumulative 5-Year FCF
-147
OCF / Net Profit
0.26
Cumulative 5-Year FCF
-147
Mar 2021
59
Cash from Investing
-65
Cash from Financing
2
-4
Free Cash Flow
-6
OCF / Net Profit
2.38
Cumulative 5-Year FCF
-143
OCF / Net Profit
2.38
Cumulative 5-Year FCF
-143
Mar 2022
11
Cash from Investing
-23
Cash from Financing
78
66
Free Cash Flow
-14
OCF / Net Profit
0.32
Cumulative 5-Year FCF
-162
OCF / Net Profit
0.32
Cumulative 5-Year FCF
-162
Mar 2023
-19
Cash from Investing
-71
Cash from Financing
50
-40
Free Cash Flow
-82
OCF / Net Profit
-0.64
Cumulative 5-Year FCF
-222
OCF / Net Profit
-0.64
Cumulative 5-Year FCF
-222
Mar 2024
-8
Cash from Investing
-74
Cash from Financing
89
7
Free Cash Flow
-75
OCF / Net Profit
-0.45
Cumulative 5-Year FCF
-261
OCF / Net Profit
-0.45
Cumulative 5-Year FCF
-261
Mar 2025
-9
Cash from Investing
-21
Cash from Financing
21
-10
Free Cash Flow
-30
OCF / Net Profit
-0.45
Cumulative 5-Year FCF
-207
OCF / Net Profit
-0.45
Cumulative 5-Year FCF
-207

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016
EPS (₹)
9.21
Book Value (₹)
39.44
Dividend per Share (₹)
0.00
Cash EPS (₹)
6.34
Operating Margin %
10.11%
Net Margin %
2.73%
ROE %
26.44%
ROCE %
34.23%
6.07%
Debtor Days
51
Inventory Days
20
Payable Days
100
-29
Debt to Equity (x)
2.27x
Interest Coverage (x)
2.01x
0.97x
Revenue Growth %
166.02%
Operating Profit Growth %
258.84%
Net Profit Growth %
74.34%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2017
EPS (₹)
15.98
Book Value (₹)
28.89
Dividend per Share (₹)
1.00
Cash EPS (₹)
12.59
Operating Margin %
14.93%
Net Margin %
6.58%
ROE %
72.40%
ROCE %
39.50%
9.67%
Debtor Days
77
Inventory Days
39
Payable Days
137
-22
Debt to Equity (x)
3.19x
Interest Coverage (x)
3.03x
1.16x
Revenue Growth %
12.31%
Operating Profit Growth %
64.69%
Net Profit Growth %
168.57%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2018
EPS (₹)
21.58
Book Value (₹)
113.31
Dividend per Share (₹)
1.00
Cash EPS (₹)
16.78
Operating Margin %
17.05%
Net Margin %
9.74%
ROE %
52.98%
ROCE %
43.66%
12.40%
Debtor Days
90
Inventory Days
37
Payable Days
102
25
Debt to Equity (x)
0.46x
Interest Coverage (x)
6.04x
2.17x
Revenue Growth %
25.72%
Operating Profit Growth %
39.15%
Net Profit Growth %
80.22%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2019
EPS (₹)
9.88
Book Value (₹)
117.19
Dividend per Share (₹)
0.50
Cash EPS (₹)
17.40
Operating Margin %
18.59%
Net Margin %
12.28%
ROE %
20.02%
ROCE %
22.80%
9.52%
Debtor Days
105
Inventory Days
41
Payable Days
97
49
Debt to Equity (x)
0.13x
Interest Coverage (x)
11.42x
3.44x
Revenue Growth %
9.94%
Operating Profit Growth %
18.79%
Net Profit Growth %
37.33%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2020
EPS (₹)
10.16
Book Value (₹)
120.81
Dividend per Share (₹)
0.25
Cash EPS (₹)
18.55
Operating Margin %
17.22%
Net Margin %
11.83%
ROE %
13.44%
ROCE %
15.87%
7.15%
Debtor Days
108
Inventory Days
41
Payable Days
129
20
Debt to Equity (x)
0.07x
Interest Coverage (x)
15.26x
2.11x
Revenue Growth %
9.22%
Operating Profit Growth %
1.15%
Net Profit Growth %
5.27%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2021
EPS (₹)
12.77
Book Value (₹)
119.70
Dividend per Share (₹)
0.50
Cash EPS (₹)
24.13
Operating Margin %
20.02%
Net Margin %
12.48%
ROE %
14.88%
ROCE %
16.59%
7.14%
Debtor Days
117
Inventory Days
28
Payable Days
156
-11
Debt to Equity (x)
0.18x
Interest Coverage (x)
15.20x
1.44x
Revenue Growth %
6.07%
Operating Profit Growth %
23.29%
Net Profit Growth %
11.88%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2022
EPS (₹)
17.67
Book Value (₹)
180.88
Dividend per Share (₹)
0.50
Cash EPS (₹)
31.25
Operating Margin %
23.77%
Net Margin %
15.95%
ROE %
16.05%
ROCE %
15.76%
8.06%
Debtor Days
118
Inventory Days
41
Payable Days
194
-35
Debt to Equity (x)
0.16x
Interest Coverage (x)
13.07x
2.12x
Revenue Growth %
8.69%
Operating Profit Growth %
29.05%
Net Profit Growth %
38.92%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2023
EPS (₹)
14.32
Book Value (₹)
182.23
Dividend per Share (₹)
0.50
Cash EPS (₹)
28.60
Operating Margin %
20.52%
Net Margin %
12.72%
ROE %
11.34%
ROCE %
11.10%
5.62%
Debtor Days
120
Inventory Days
88
Payable Days
193
16
Debt to Equity (x)
0.25x
Interest Coverage (x)
7.53x
1.82x
Revenue Growth %
9.17%
Operating Profit Growth %
-5.74%
Net Profit Growth %
-12.93%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2024
EPS (₹)
8.17
Book Value (₹)
213.30
Dividend per Share (₹)
0.50
Cash EPS (₹)
19.61
Operating Margin %
14.89%
Net Margin %
6.64%
ROE %
6.08%
ROCE %
8.41%
2.87%
Debtor Days
115
Inventory Days
118
Payable Days
154
79
Debt to Equity (x)
0.26x
Interest Coverage (x)
3.60x
1.85x
Revenue Growth %
16.44%
Operating Profit Growth %
-7.26%
Net Profit Growth %
-39.23%
-42.92%
P/E (x)
70.67x
P/B (x)
2.71x
Dividend Yield %
0.09%
21.22x
Mar 2025
EPS (₹)
10.60
Book Value (₹)
218.42
Dividend per Share (₹)
0.50
Cash EPS (₹)
22.98
Operating Margin %
13.12%
Net Margin %
6.55%
ROE %
6.04%
ROCE %
7.69%
2.88%
Debtor Days
107
Inventory Days
129
Payable Days
135
101
Debt to Equity (x)
0.30x
Interest Coverage (x)
3.34x
1.77x
Revenue Growth %
14.21%
Operating Profit Growth %
10.27%
Net Profit Growth %
12.65%
29.70%
P/E (x)
59.08x
P/B (x)
2.87x
Dividend Yield %
0.08%
21.61x

Shareholding Pattern

Numbers in percentages

TRADES
Jun 2024
47.95
2.15
0.88
Government
0.00
49.01
Sep 2024
47.95
2.16
0.88
Government
0.00
47.88
Dec 2024
47.95
3.21
0.88
Government
0.00
46.83
Mar 2025
47.37
3.17
0.64
Government
0.00
47.71
Jun 2025
47.37
3.25
0.56
Government
0.00
47.71
Sep 2025
47.37
3.27
0.48
Government
0.00
47.77
Dec 2025
47.37
3.36
0.12
Government
0.00
48.61
Mar 2026
47.37
3.66
0.00
Government
0.00
48.42
Jun 2026
47.37
0.66
0.02
Government
0.00
51.41

Documents

Announcements

  • Copy of Newspaper Publication

    2026-08-17 - Shivalik Rasayan Limited has informed the Exchange about Copy of Newspaper Publication

  • General Updates

    2026-08-14 - Shivalik Rasayan Limited has informed the Exchange about submission of BRSR report

Credit Ratings

Nothing filed yet.

Concalls

  • Nov 2024

    TranscriptPPTREC
  • Dec 2021

    TranscriptPPTREC
  • Sep 2021

    TranscriptPPTREC